European Commission restructures health and consumers department
This article was originally published in RAJ Devices
Executive Summary
DG SANCO, the European Commission's Health and Consumers Directorate General, is being restructured partly in an attempt to make the department better able to help facilitate the introduction of innovative solutions in the area of health. The changes, which involve the creation of a new directorate and a new advisory post on innovation reporting directly to the head of DG SANCO, will result in public health issues being managed separately from health systems and products1,2.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.